Biologics Quality Control Testing

ABOUT US

PathoQuest, a spin-out of Institut Pasteur Paris, is a genomics expert company offering a game-changing next-generation sequencing (NGS) approach for microbiology testing.

The NGS-based technology the company has developed is used for:

• The quality control (QC) testing of biologicals (e.g., ATMP, vaccines, antibodies), enabling rapid and robust analysis at a GMP level

PathoQuest’s technology leverages the company’s proprietary sample preparation protocols, which are applicable to several types of biological samples, proprietary internally-curated pathogen genome databases, and automated analysis pipelines.

LATEST NEWS

PathoQuest to Participate in the CPHi Bioproduction event in Messe Frankfurt, Germany | 01-03 Nov. 2022

PathoQuest to Participate in the CPHi Bioproduction event in Messe Frankfurt, Germany | 01-03 Nov. 2022

Learn from today’s leading CDMOs and biopharmaceutical companies.
The scientific agenda for BioProduction 2022 features presentations across 3 tracks covering today’s novel science and technologies designed to improve efficiencies across all phases of biopharmaceutical manufacturing:
Upstream Processing / Downstream Processing / Manufacturing, Supply Chain and Business Strategy

read more
w

Let’s Start Something New

Welcome to PathoQuest!

4 + 3 =

EnglishFrenchGermanSpanish